Cantor Fitzgerald Reiterates Amarin Corporation (AMRN) at Overweight, "Street is Underestimating Multi-billion Dollar Opportunity for Vascepa/Vazkepa"
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $10.00 price target on Amarin Corporation (NASDAQ: AMRN), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
